Kathleen Large is a seasoned biopharmaceutical leader with over 20 years of experience in global clinical development. As SVP and Head of Clinical Operations at Trillium Therapeutics, a Pfizer company, she leverages expertise gained from leadership roles at Aileron, Epizyme, and Millennium. She holds degrees from Boston College and the University of California, San Francisco.
She steered her companys clinical operations through its acquisition by Pfizer, a major pharmaceutical corporation.
Kathleen Large
Senior Vice President, Head of Clinical Operations at Trillium Therapeutics Inc.
Greater Boston, United States
Overview
Topics They Care About
Oncology Clinical Trials
Her career is focused on leading clinical operations for companies developing novel cancer therapies, including at Trillium, Aileron, and Epizyme.
Biopharma Operations
Possesses more than two decades of senior experience managing global clinical development and operations for various biotechnology companies.
Drug Development Lifecycle
As a senior executive, she has consistently overseen the entire clinical development pipeline from strategic planning through to execution.
Media Appearances
Kathleen has no verified media appearances
Work History
8-2019
Senior Vice President, Head of Clinical Operations at Trillium Therapeutics Inc.
6-2018 - 1-2019
Vice President Development Operations at Aileron Therapeutics
8-2016 - 6-2018
Vice President Clinical Operations at Epizyme
7-2014 - 10-2015
Vice President, Clinical Operations at Histogenics Corporation
1-2012 - 6-2014
Director, Clinical Operations at Millennium Pharmaceuticals
8-2009 - 2-2012
Director, Oncology, Early Phase Medical at Eli Lilly & Co
Education
Bachelor of Science (B.S.) from Boston College
Master's degree from University of California, San Francisco
More Information
Social Presence :
Prographics :
Exp : 15
Location : Greater Boston, United States
Job Level : Leadership
Designation : Senior Vice President, Head of Clinical Operations at Trillium Therapeutics Inc.
